Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Product Launch

23 Sep 2009 07:00

RNS Number : 4943Z
Imaginatik PLC
23 September 2009
 



23 September 2009

Imaginatik plc

("Imaginatik" or the "Company")

Launch of ChemBioConnect

CambridgeSoft and Imaginatik launch Visual Collaboration Tool for Scientists

Imaginatik plc (AIM: IMTK), a leading provider of enterprise collaboration software, announces the launch of ChemBioConnect, an online collaboration tool for use by researchers in the chemistry, biotechnology and pharmaceutical industries.

Developed in conjunction with CambridgeSoft, ChemBioConnect allows scientists to draw, view, edit, archive and search chemical structures and biological systems in a secure, robust collaboration and idea management environment. The resource effectively allows for collaborative problem-solving among scientists by combining CambridgeSoft's chemically intelligent visual toolsets with Imaginatik's research-based, enterprise-scale system, comprised of software, services and a deep understanding of how human networks operate. This offering is targeted to meet the needs of research and development professionals in the areas of pharmaceuticals, bioscience, biotechnology, chemistry and food science.

"Professional chemists think and communicate visually, whether doodling on paper, working in teams at a whiteboard, or keeping a notebook," said Dr. Robin Spencer, Senior Research Fellow at Pfizer, Inc. "At Pfizer we have seen that marrying the ability to work visually with a secure collaborative innovation environment like ChemBioConnect gives our scientists a scalable and secure new way to capture ideas and solve challenging problems."

"Collaboration is vital in all forms of business activity, and chemistry and biology are not exceptions to this rule," said Mark Turrell, CEO of Imaginatik. "ChemBioConnect is the first in a series of industry specific modules of our core collaboration software platform, Idea Central, which we intend to launch in the years ahead, supporting our growth and market leadership position." 

"We are pleased to be working together with Imaginatik," said Michael G. Tomasic, President and CEO of CambridgeSoft. "With this collaboration we are ensuring that our customers benefit from the integration of CambridgeSoft's leading chemical and biological drawing software, ChemBioDraw, with Imaginatik's innovation engine to drive collaborative problem solving for new research insights and higher efficiency."

ChemBioConnect is being sold by Imaginatik with support from CambridgeSoft.

For further information please contact:

Imaginatik plc

Tel: 020 7917 2975

Mark Turrell, CEO / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

ICIS

Tel: 020 7651 8688

Caroline Evans-Jones / Hilary Millar

About Imaginatik

Imaginatik is the leading provider of Collective Intelligence solutions, including Collaborative Innovation, Open Innovation and Idea Management technology and services. Some of the leading companies in the world use Imaginatik's Idea Central software platform to identify and develop the important ideas and strategies that will drive the future of their business. For more than 10 years, Imaginatik has helped customers including CSC, Pfizer, Boeing, Chubb and Cargill achieve outstanding results with its highly configurable web-based software and experienced consulting team.

A World Economic Forum Technology Pioneer with offices in Boston, MA, and London, UK, Imaginatik is committed to ongoing research into the nature of human networks, innovation and collective problem solving. The company collaborates with several academic institutions including the IXL Center at Hult International Business School. Imaginatik is publicly traded on the London Stock Exchange [AIM:IMTK.L].

For further information please visit http://www.imaginatik.com

About CambridgeSoft

CambridgeSoft develops and markets life science enterprise solutions for pharmaceutical, biotechnology, chemical companies and scientific research organizations. Software products include enterprise, workgroup and desktop versions of Chem & Bio Office, including Chem & Bio Draw and E-Notebook, with knowledge management, chemical and biological informatics, and scientific database solutions. Web sites include ChemBioFinder.Com and ChemBioNews.Com for indexed database content and news, and SciStore.Com for e-commerce. CambridgeSoft has offices in the United StatesEurope and Asia Pacific. For more information, please go to www.cambridgesoft.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPUUPPBUPBGQP
Date   Source Headline
15th Jun 20107:00 amRNSAppointment of Chief Operating Officer
1st Jun 20103:48 pmRNSHolding(s) in Company
13th May 20107:00 amRNSAppointment of Interim Vice President of Sales
6th May 20102:11 pmRNSHolding(s) in Company
28th Apr 20107:00 amRNSTrading Update
10th Mar 20107:00 amRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNSTrading Update
22nd Feb 20107:00 amRNSWindsor Foods Selects Imaginatik
17th Feb 20109:45 amRNSDirector Shareholding
29th Jan 201011:41 amRNSContract Win
22nd Dec 20097:00 amRNSDirectorate Change
17th Dec 20097:00 amRNSContract Win with Global Consumer Products Company
11th Dec 20097:00 amRNSContract Extension
17th Nov 20097:00 amRNSInterim Results
13th Nov 20097:00 amRNSContract Win
12th Nov 20097:00 amRNSNotice of Results
9th Oct 20097:00 amRNSTrading Update & Directorate Change
2nd Oct 20097:00 amRNSContract Win with global technology business
28th Sep 20097:00 amRNSContract Win with US Insurer
24th Sep 20097:00 amRNSDirector/PDMR Shareholding
23rd Sep 20097:00 amRNSProduct Launch
10th Sep 20097:00 amRNSContract Win
8th Sep 20097:00 amRNSWorld Economic Forum
13th Aug 20094:26 pmRNSHolding(s) in Company
13th Aug 20093:00 pmRNSHolding(s) in Company
13th Aug 200911:18 amRNSDirector/PDMR Shareholding
12th Aug 20095:17 pmRNSAdditional Listing
10th Aug 20097:00 amRNSPlacing
28th Jul 20097:00 amRNSAGM Statement
3rd Jul 20092:21 pmRNSDirector/PDMR - Share Subscription
29th Jun 20092:34 pmRNSAnnual Report & Accounts
17th Jun 20097:00 amRNSFinal Results
2nd Jun 20097:00 amRNSChange of Adviser & Notice of Results
15th May 200910:33 amRNSDirectorate Change
3rd Apr 20097:00 amRNSContract Win & Trading Update
19th Mar 20097:00 amRNSContract Extension with Chubb
5th Feb 20097:00 amRNSManagement Appointment
23rd Jan 20094:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20097:00 amRNSWorld Economic Forum
15th Jan 20097:00 amRNSTrading on PLUS
14th Jan 20093:10 pmRNSDirector/PDMR Shareholding
14th Jan 20097:00 amRNSPharmaceutical Contract Win
9th Jan 20099:09 amRNSDirector/PDMR Shareholding
7th Jan 20091:35 pmRNSDirector/PDMR Shareholding
5th Jan 200911:10 amRNSDirector/PDMR Shareholding
5th Jan 20099:40 amRNSDirector/PDMR Shareholding
2nd Jan 20099:05 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSTotal Voting Rights
24th Dec 200810:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.